GENERAL CARDIOLOGY: Diabetic heart disease: clinical considerations
Open Access
- 1 April 2001
- Vol. 85 (4) , 463-469
- https://doi.org/10.1136/heart.85.4.463
Abstract
Three large epidemiological studies have shaped current understanding of the natural history of diabetic heart disease. The Framingham study showed that diabetes increased the relative risk of coronary heart disease by 66% in men and 203% in women followed up for 20 years, after controlling for the effects of age, smoking, blood pressure, and cholesterol.1 The Whitehall study of male civil servants extended these observations by showing that subclinical glucose intolerance, in addition to frank diabetes, also increased coronary risk.2 The MRFIT trial, with its very large population of middle aged men, was able to provide more detailed information about the interaction between diabetes and other risk factors in determining coronary risk.3 This trial confirmed the heightened risk attributable to diabetes, and also the independent effects of serum cholesterol, blood pressure, and smoking in men with and without diabetes. MRFIT showed that in men with diabetes, 12 year cardiovascular mortality was much higher at every level of these major risk factors considered singly and in combination, and that with progressively more unfavourable risk factor status the mortality rate rose much more steeply than in men without diabetes (fig1).Keywords
This publication has 12 references indexed in Scilit:
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Optimizing the Percutaneous Interventional Outcomes for Patients With Diabetes MellitusCirculation, 1999
- Diabetes mellitus and congestive heart failureEuropean Heart Journal, 1999
- Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery DiseaseCirculation, 1996
- Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 yearJournal of the American College of Cardiology, 1995
- Silent myocardial ischemia: Role of subclinical neuropathy in patients with and without diabetesJournal of the American College of Cardiology, 1993
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993
- Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patientsDiabetologia, 1991
- Prolonged anginal perceptual threshold in diabetes: Effects on exercise capacity and myocardial ischemiaJournal of the American College of Cardiology, 1990
- Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.BMJ, 1983